• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I ANTI-HCV REAGENT KIT; ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I ANTI-HCV REAGENT KIT; ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS Back to Search Results
Catalog Number 08P06-74
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/01/2022
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed false nonreactive alinity i anti-hcv results on one patient.The results provided were: on (b)(6) 2022 initial= 0.55 s/co (< 1.00 s/co=nonreactive)) /repeated= 0.45 s/co, 0.89 s/co and 0.99 s/co /repeated after re-centrifuged=nonreactive (no actual results provided) /repeated with new lot of reagent=2.48 s/co (> or = 1.00 s/co=reactive) /previous history in (b)(6) =2.36 s/co there was no reported impact to patient management.
 
Manufacturer Narrative
The complaint evaluation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and field data of alinity i anti-hcv reagent lot 40373be01.The evaluation of complaint data for the product and likely cause alinity i anti-hcv reagent lot 40373be01 identified as expected.Trending review determined no adverse trend for the issue for the product.The ticket trending review of at least 12 months complaint data for the likely cause list number does not identify any adverse or non-statistical trend.Device history record review did not identify any non-conformances or deviations with the complaint lot and complaint issue.The return specimen was tested with a retained kit of alinity i anti-hcv reagent lot number 40373be01.Reactive results (2.33 s/co/ 2.00 s/co/ 2.11 s/co) were obtained.Further mikorgen recomline hcv igg testing was performed.Two weak bands (ns3 and helicase) with intensity below the cut off were identified.The interpretation is negative.Historical performance of the alinity i anti-hcv reagents in the field using data gathered via abbottlink from customers worldwide.The number of standard deviations to the cut-off for the negative populations and the median values, determined the likely cause lots are within their established limits.A review of the manufacturing documentation did not identify any issues associated with the customer¿s observation.There was no issue with reagent performance identified.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the alinity i anti-hcv reagent lot number 40373be01.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I ANTI-HCV REAGENT KIT
Type of Device
ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key15781030
MDR Text Key307601181
Report Number3002809144-2022-00395
Device Sequence Number1
Product Code MZO
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/21/2023
Device Catalogue Number08P06-74
Device Lot Number40373BE01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/19/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODULE, 03R65-01, (B)(6) ; ALNTY I PROCESSING MODULE, 03R65-01, (B)(6)
-
-